AR and Retinal dystrophy: Even though AR has been used as a standard XCI marker for several studies, including retinal dystrophies (Allen et al, 1992; Fahim et al, 2020; Wang et al, 2021), we herein suggest that several XCI markers should be compared with minimize the risk of false positive or false negative results.